Interventions for preventing bone disease in kidney transplant recipients-Reference-Cited by-同舟云学术

Interventions for preventing bone disease in kidney transplant recipients

Published:2007-07-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Palmer Suetonia C¹,McGregor David O²,Strippoli Giovanni FM³

Affiliation:

1. Brigham and Women's Hospital, Harvard Medical School; Renal Division; Harvard Institute of Medicine, Room 550 4 Blackfan Street Boston MA USA 02115

2. Christchurch Hospital; Department of Nephrology; Private Bag 4710 Christchurch New Zealand 8001

3. The Children's Hospital at Westmead; Centre for Kidney Research; Locked Bag 4001 Westmead NSW Australia 2145

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD005015.pub3/fullpdf

Reference115 articles.

1. Randomized trial of IV pamidronate to ameliorate bone loss in renal transplant (rt) recipients [abstract];Coco;Journal of the Amercian Society of Nephrology,2001

2. Prospective randomised trial of IV pamidronate in renal transplant recipients: 6 and 12 month follow-up [abstract];Coco;Journal of the American Society of Nephrology,2002

3. Effect of IV pamidronate on bone biochemical parameters in renal transplant recipients [abstract];Coco;Journal of the Amercian Society of Nephrology,2000

4. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate;Coco;Journal of the American Society of Nephrology,2003

5. Pamidronate used to attenuate post-renal transplant bone loss is not associated with renal dysfunction;Lee;Nephrology Dialysis Transplantation,2004

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management;International Journal of Molecular Sciences;2024-02-03

2. The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients;Biomolecules;2023-03-31

3. Kidney Transplantation, Immunosuppression and the Risk of Fracture: Clinical and Economic Implications;Kidney Medicine;2022-06

4. The Effect of Alendronate on Bone Mineral Disorder in Renal Transplant Patients;Transplantation Proceedings;2022-04

5. KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation;Transplantation;2020-04